The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- Elan Corp. (NYSE: ELN) and its development partners, Pfizer (NYSE: PFE) and Johnson and Johnson (NYSE:JNJ), announced that their Alzheimer’s treatment candidate, bapineuzumab, did not … Continue Reading
Read nowLong Ideas - Novartis AG (NYSE:NVS) announced this morning that its generics division, Sandoz, has completed takeover of private dermatology provider Fougera Pharmaceuticals in a $1.5B deal. Although … Continue Reading
Read now- Synergy Pharmaceuticals (NASDAQ: SGYP) announced Friday that it plans to merge with Callisto Pharmaceuticals (NASDAQ: CLSP), which happens to be Synergy’s largest shareholder. SGYP is … Continue Reading
Read now- Onyx Pharmaceuticals (NASDAQ:ONXX) just announced FDA approval of Kyprolis (carfilzomib), ONXX’s next-generation treatment for multiple myeloma. The FDA action (PDUFA) date was set for July … Continue Reading
Read now- Pluristem (NASDAQ:PSTI) continues its upward trend this morning on news Wednesday that the company is partnering with CPC Clinical Research to begin a Phase II … Continue Reading
Read now- In an 8k filing posted last night, Sucampo Pharmaceuticals (NASDAQ: SCMP) announced that it would not renew COO James Egan’s employment agreement, which expires on … Continue Reading
Read nowLong Ideas - Among the next significant events in pharma and biotech is the FDA decision on Kyprolis (carfilzomib), Onyx Pharmaceuticals’ (NASDAQ:ONXX)next-generation treatment for multiple myeloma. On July … Continue Reading
Read now
